Brief: Allergy Therapeutics Sees H2 Sales Slightly Higher Than Previous Year
March 27 (Reuters) - Allergy Therapeutics PLC AGY.L :
* ALLERGY THERAPEUTICS PLC - IN SECOND HALF OF FINANCIAL
YEAR,
SALES ARE EXPECTED TO BE SLIGHTLY HIGHER THAN PREVIOUS YEAR
* ALLERGY THERAPEUTICS PLC - OVERALL SALES FOR FULL YEAR
ENDING ON
30 JUNE 2024 ARE EXPECTED TO BE SLIGHTLY LOWER THAN
CORRESPONDING PERIOD
Source text for Eikon: ID:nRSa4174Ia
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsBrief: Allergy Therapeutics Expects FY 2026 Revenue Of £59.90 Million, Up 9% Reported
UK's Allergy Therapeutics FY revenue beats on Grassmuno launch
Allergy Therapeutics - Trading update for the year ended 30 June 2026
Brief: Allergy Therapeutics Appoints Helge Weiner-Trapness As Executive Chairman
Allergy Therapeutics - Appointment of Executive Chairman